Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin (Crestor®)
Clinical trial NCT02859129 · COMPLETED
Trial details
- NCT number
- NCT02859129
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2013-11-01
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.